Colon cancer is a malignancy that starts in the cells lining the inner wall of the large intestine (colon). It develops when normal cells in this lining accumulate DNA damage, causing them to grow uncontrollably and form tumors. Most colon cancers begin as small, noncancerous growths called polyps that slowly transform into cancer over many years, often 15 to 20 years. This long progression is what makes screening so effective: catching and removing polyps before they turn cancerous can prevent the disease entirely.
How Colon Cancer Develops
The inside of your colon is lined with a layer of epithelial cells that constantly renew themselves. When these cells are exposed to cancer-causing factors, whether from genetics, diet, or other sources, their DNA can become damaged. This doesn’t happen all at once. The cells first begin to multiply faster than normal (hyperplasia), then develop increasingly abnormal features, then form a polyp called an adenoma. Over time, additional genetic mutations can push that adenoma to become a full-blown carcinoma.
Research from genome sequencing studies estimated that the formation of adenomas takes an average of 17 years, while the leap from a large cancerous tumor to distant spread (such as to the liver) can happen in less than two years. This timeline matters because it means there’s a wide window to detect and remove precancerous polyps, but once a cancer becomes advanced, it can progress quickly. Some polyps, however, defy the typical timeline and progress faster than expected, which is one reason regular screening matters even for people who feel perfectly healthy.
Symptoms to Watch For
Early colon cancer often causes no symptoms at all, which is why screening is so important. When symptoms do appear, they tend to involve changes in how your bowels work or look. Common warning signs include:
- Persistent changes in bowel habits: diarrhea, constipation, or a noticeable change in the size, shape, or frequency of your stool that doesn’t go away
- Blood in the stool or rectal bleeding: this can appear as bright red blood or make stool look very dark
- Abdominal discomfort: cramping, bloating, or a feeling of fullness in the lower stomach
- Unexplained weight loss or fatigue: losing weight without dieting or feeling exhausted despite adequate rest
- A persistent urge to have a bowel movement even when there’s no need
None of these symptoms are unique to colon cancer. Many are caused by far more common conditions like hemorrhoids, irritable bowel syndrome, or infections. But if any of them persist for more than a few weeks, that warrants a conversation with a doctor.
Risk Factors
Colon cancer risk is shaped by a combination of things you can’t control and things you can. On the genetic side, about 5 to 10 percent of all colon cancers stem from inherited conditions. The most significant is Lynch syndrome (also called hereditary nonpolyposis colorectal cancer), which accounts for roughly 3 to 4 percent of all cases and carries a lifetime risk of developing colon cancer between 70 and 80 percent. Lynch syndrome is caused by mutations in genes responsible for repairing DNA damage, and people with it also face elevated risks of cancers in the uterus, kidneys, and other organs. Familial adenomatous polyposis is another inherited condition that causes hundreds or thousands of polyps to form in the colon, almost guaranteeing cancer if left untreated.
Lifestyle factors play a substantial role for the majority of cases that aren’t inherited. A diet low in fruits, vegetables, and fiber but high in red meat and saturated fat increases risk. Sedentary behavior is associated with roughly 60 percent higher odds of developing the disease. Obesity, smoking, and heavy alcohol use are also well-established contributors. The encouraging flip side: regular physical activity, a plant-rich diet, and maintaining a healthy weight are among the most effective ways to lower your risk.
How Colon Cancer Is Staged
Staging describes how far the cancer has spread, and it’s the single biggest factor in determining treatment and prognosis. Doctors use a system based on three elements: how deep the tumor has grown into the colon wall (T), whether it has reached nearby lymph nodes (N), and whether it has spread to distant organs (M).
In practical terms, the stages break down like this:
- Stage 0: Abnormal cells are only in the innermost lining of the colon. This is sometimes called carcinoma in situ and is highly curable.
- Stage I: The cancer has grown into the colon wall but hasn’t reached nearby lymph nodes or spread anywhere else.
- Stage II: The tumor may have grown through the colon wall and possibly into nearby tissue, with limited or no lymph node involvement.
- Stage III: Cancer has spread to nearby lymph nodes but not to distant parts of the body.
- Stage IV: The cancer has metastasized to distant organs, most commonly the liver or lungs.
Survival Rates by Stage
Five-year relative survival rates, based on data from the National Cancer Institute’s SEER program, show how dramatically stage at diagnosis affects outcomes. When colon cancer is found while still localized (confined to the colon), the five-year survival rate is 91.3 percent. For regional disease, meaning it has spread to nearby lymph nodes, that rate drops to 75.2 percent. When the cancer has metastasized to distant organs, five-year survival falls to 16.9 percent.
These numbers underscore why early detection matters so much. About 37 percent of colon cancers are diagnosed at the localized stage, but a significant portion are still caught after they’ve already spread, when treatment becomes more difficult and less likely to be curative.
Screening Recommendations
The U.S. Preventive Services Task Force recommends that all adults at average risk begin colon cancer screening at age 45 and continue through age 75. Several screening methods are available, and they differ in how often they need to be repeated:
- Stool-based tests: A fecal immunochemical test (FIT) or a high-sensitivity guaiac test is done yearly. A stool DNA-FIT test is done every one to three years. These are noninvasive and done at home.
- Colonoscopy: Done every 10 years. It’s the most thorough option because it lets doctors both see and remove polyps during the same procedure.
- CT colonography (virtual colonoscopy): Done every 5 years using imaging rather than a scope.
- Flexible sigmoidoscopy: Examines only the lower portion of the colon. Done every 5 years alone, or every 10 years when combined with annual FIT.
If you have a family history of colon cancer, Lynch syndrome, or inflammatory bowel disease, your doctor will likely recommend starting screening earlier and doing it more frequently than these general guidelines suggest.
Treatment Options
Surgery is the primary treatment for colon cancer that hasn’t spread to distant organs. The standard approach involves removing the section of colon that contains the tumor along with nearby lymph nodes. For early-stage cancers, surgery alone is often curative.
For Stage III disease, where cancer has reached the lymph nodes, chemotherapy after surgery (called adjuvant chemotherapy) is standard. This aims to kill any remaining cancer cells and reduce the chance of recurrence. For Stage II cancer, the benefit of chemotherapy is less clear, and it’s typically only recommended in specific higher-risk situations.
Stage IV colon cancer, where the disease has spread to distant organs, requires a more complex approach. Treatment often involves combinations of chemotherapy with targeted therapies that block specific pathways cancer cells use to grow and survive. Some of these targeted drugs work by cutting off blood supply to tumors, while others target specific genetic mutations found in the cancer cells. The choice of treatment increasingly depends on the genetic profile of the tumor itself, which is why doctors routinely test colon cancers for certain mutations that predict which therapies will be most effective.
Radiation therapy plays a limited role in colon cancer compared to rectal cancer, but it may be used in specific situations, such as when the tumor is fixed to a nearby structure or to manage pain from metastatic disease.